Industry Report
Pharma & Healthcare
Dietary supplements market in Poland 2026
Market analysis and development forecasts for 2026-2031
According to the latest PMR Forecasts included in the report “The Dietary Supplements Market in Poland 2020,” sales of dietary supplements in Poland—both in pharmacies and elsewhere (in stores, at gas stations, and all other retail outlets, including, for example, gyms) will increase by 2.6% in 2020 and reach a value of nearly 6 billion PLN at retail prices*.
Sales of dietary supplements in pharmacies that remained open during the lockdown are driving market growth—particularly in March 2020, when historically record-breaking increases were recorded. At the same time, we estimate that the value of non-pharmacy sales in 2020 will decline by 1% (in the base case scenario). As for supplement categories, products for immunity and those used to treat infections, as well as vitamins and minerals, will sell best.
The factor that could have the greatest impact on the growth of the dietary supplement market is, once again—as in the previous edition of the study—consumer awareness of these products. Currently, the stability of these findings may be due to the belief that, in the face of the coronavirus pandemic, people will place greater emphasis on preventive measures, which will also be reflected in the use of dietary supplements, according to a survey conducted by PMR among 100 companies operating in the dietary supplement market in Poland.
As many as one-third of respondents cite an improvement in the economic situation as a factor—which is understandable given the forecasts for 2020, which predict an economic recession. As a result of declining sales, more companies than in previous editions of the survey are also counting on intensifying their marketing efforts and seeking external financial assistance, such as from the EU.

Other factors mentioned by companies that could influence the growth of their businesses include:
* according to one of the scenarios presented in the report—namely, the baseline scenario, which assumes a relatively stable number of COVID-19 cases through the end of the year and no return to restrictions
OTHER BLOG POSTS: